Page last updated: 2024-10-31

metoclopramide and Craniopharyngioma

metoclopramide has been researched along with Craniopharyngioma in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Craniopharyngioma: A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbarino, A1
De Marinis, L1
Mancini, A1
Menini, E1
D'Amico, C1
Passeri, M1
Sambo, P1
Anile, C1
Maira, G1

Other Studies

1 other study available for metoclopramide and Craniopharyngioma

ArticleYear
Prolactin dynamics in patients with non-secretin tumours of the hypothalamic-pituitary region.
    Acta endocrinologica, 1985, Volume: 110, Issue:1

    Topics: Adenoma; Adenoma, Chromophobe; Adolescent; Adult; Craniopharyngioma; Female; Follicle Stimulating Ho

1985